孤立性乙型肝炎核心抗体:乙型肝炎核心抗体的相关性——新问题综述
乙型肝炎核心抗体(anti-HBc)被认为是乙型肝炎病毒(HBV)感染史最敏感的血清学标志物。部分anti-HBc携带者中,anti-HBc阳性而乙型肝炎表面抗原和表面抗体均阴性,称为「孤立性anti-HBc」(IAHBc)。本文综述IAHBc作为隐匿性HBV感染(OBI)血清学标志物的临床意义,及其与丙型肝炎病毒(HCV)合并感染、HCV直接抗病毒治疗及免疫抑制期间HBV再激活风险、肝细胞癌(HCC)发生的关系,并强调乙型肝炎核心相关抗原作为新兴实验室检测可能识别OBI并预测接受核苷(酸)类似物治疗的非肝硬化患者HCC发生。
要点
- anti-HBc是HBV感染史最敏感的血清学标志物。
- IAHBc指anti-HBc阳性而HBsAg和anti-HBs均阴性。
- IAHBc可能作为隐匿性HBV感染的血清学标志物。
核心结论
- IAHBc作为OBI血清学标志物的作用日益受到关注,并与HCV合并感染、HBV再激活风险及HCC发生相关。
研究设计与样本
- 本文为综述,回顾IAHBc的临床意义及其与HCV合并感染、直接抗病毒治疗和免疫抑制期间HBV再激活、HCC发生的关系。
主要发现
- IAHBc指anti-HBc阳性而HBsAg和anti-HBs均阴性。
- IAHBc可能作为隐匿性HBV感染的血清学标志物。
- 乙型肝炎核心相关抗原是新兴实验室检测,可能识别OBI并预测接受核苷(酸)类似物治疗的非肝硬化患者HCC发生。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis B core antibody (anti-HBc) is considered the most sensitive serological marker for history of hepatitis B virus (HBV) infection. In a subset of anti-HBc carriers, anti-HBc is present in the absence of hepatitis B surface antigen and hepatitis B surface antibody-a serological pattern known as "isolated anti-HBc" (IAHBc). IAHBc has been of clinical interest over the past several years, with growing data to suggest its role as a serological marker for occult HBV infection (OBI). This article reviews the clinical significance and association of IAHBc with hepatitis C virus (HCV) co-infection, risk of HBV reactivation during direct-acting antiviral therapy for HCV as well as immune suppression, and development of hepatocellular carcinoma (HCC). Hepatitis B core-related antigen is also highlighted as an emerging laboratory assay that may identify OBI and predict HCC development in non-cirrhotic patients receiving nucleoside/nucleotide analog therapy.
引用
- Wu T, Kwok RM, Tran TT, et al. Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues. Am J Gastroenterol. 2017. PMID: 29087395. doi:10.1038/ajg.2017.397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。